3 years ago

SERG Technologies Secures £1.6 Million for Parkinson's Disease Diagnosis Device

  • SERG Technologies, a London-based developer of a Parkinson's disease diagnosis and monitoring device, has raised £1.6 million in funding

  • The investment will be used to gain regulatory approval for the system in the UK and US and explore potential treatment options

  • Founded in 2019 by Dr

  • Ravi Vaidyanathan and Dr

  • Sam Wilson, SERG's NuRO platform utilizes acoustic sensors to assess muscle state, offering a more objective approach to symptom identification and severity measurement

  • The company intends to use the funding to achieve regulatory approval and explore potential treatment applications.

      • ProblemHealthcare

      "Early diagnosis of Parkinson's disease is challenging, leading to delayed treatment and poorer outcomes. Existing methods rely on subjective assessments and are not always accurate. "

      Solution

      "SERG Technologies has developed a device that uses acoustic sensors to objectively detect movement and assess muscle state, providing a more accurate and reliable method for diagnosing and monitoring Parkinson's disease. This allows for earlier diagnosis, better disease management, and potential for future treatments."

      Covered on